Free Trial

Acutus Medical Q3 2023 Earnings Report

Acutus Medical logo
$0.05 0.00 (-3.55%)
As of 10:44 AM Eastern

Acutus Medical EPS Results

Actual EPS
-$0.45
Consensus EPS
-$0.57
Beat/Miss
Beat by +$0.12
One Year Ago EPS
N/A

Acutus Medical Revenue Results

Actual Revenue
$5.24 million
Expected Revenue
$5.10 million
Beat/Miss
Beat by +$140.00 thousand
YoY Revenue Growth
N/A

Acutus Medical Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Remove Ads

Acutus Medical Earnings Headlines

Comparing InfuSystem (NYSE:INFU) & Acutus Medical (NASDAQ:AFIB)
Crypto Genius: 12,000% in 12 months? [Here’s how]
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Acutus Medical Announces Operational Downsizing
Acutus Medical Reports Q3 2024 Financial Results
See More Acutus Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Acutus Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Acutus Medical and other key companies, straight to your email.

About Acutus Medical

Acutus Medical (NASDAQ:AFIB) designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

View Acutus Medical Profile

More Earnings Resources from MarketBeat